Pathway analysis using random forests with bivariate node-split for survival outcomes
暂无分享,去创建一个
[1] L. Altucci,et al. RAR and RXR modulation in cancer and metabolic disease , 2007, Nature Reviews Drug Discovery.
[2] K. Hornik,et al. Unbiased Recursive Partitioning: A Conditional Inference Framework , 2006 .
[3] R. Tibshirani,et al. On testing the significance of sets of genes , 2006, math/0610667.
[4] Wei Pan,et al. Incorporating prior knowledge of predictors into penalized classifiers with multiple penalty terms , 2007, Bioinform..
[5] Lawrence C. Brody,et al. BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage , 2002, Nature Genetics.
[6] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[7] P. Hall,et al. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[8] Aleksandra M. Michalowska,et al. Transforming Growth Factor-β Can Suppress Tumorigenesis through Effects on the Putative Cancer Stem or Early Progenitor Cell and Committed Progeny in a Breast Cancer Xenograft Model , 2007 .
[9] R. Hesketh,et al. Inhibiting mutations in the transforming growth factor beta type 2 receptor in recurrent human breast cancer. , 2001, Cancer research.
[10] S. Ménard,et al. Expression of protein tyrosine phosphatase alpha (RPTPα) in human breast cancer correlates with low tumor grade, and inhibits tumor cell growth in vitro and in vivo , 2000, Oncogene.
[11] E. Dougherty,et al. Gene-expression profiles in hereditary breast cancer. , 2001, The New England journal of medicine.
[12] Allan Balmain,et al. TGF-β signaling in tumor suppression and cancer progression , 2001, Nature Genetics.
[13] Hongyu Zhao,et al. Pathway analysis using random forests classification and regression , 2006, Bioinform..
[14] Lu Tian,et al. Linking gene expression data with patient survival times using partial least squares , 2002, ISMB.
[15] Anne-Laure Boulesteix,et al. Survival prediction using gene expression data: A review and comparison , 2009, Comput. Stat. Data Anal..
[16] Y Pawitan,et al. Gene expression profiling for prognosis using Cox regression , 2004, Statistics in medicine.
[17] Frederic D Sigoillot,et al. Breakdown of the regulatory control of pyrimidine biosynthesis in human breast cancer cells , 2004, International journal of cancer.
[18] Yi Lin,et al. Random Forests and Adaptive Nearest Neighbors , 2006 .
[19] R. Millikan,et al. Radiation clastogenesis and cell cycle checkpoint function as functional markers of breast cancer risk. , 2006, Carcinogenesis.
[20] I. Ellis,et al. Do poor-prognosis breast tumours express membrane cofactor proteins (CD46)? , 2005, Cancer Immunology, Immunotherapy.
[21] N. Hynes,et al. BAD: a good therapeutic target? , 2002, Breast Cancer Research.
[22] M. Mathews,et al. Human breast cancer cells contain elevated levels and activity of the protein kinase, PKR , 2000, Oncogene.
[23] J. Massagué,et al. G1 cell-cycle control and cancer , 2004, Nature.
[24] D. Weaver,et al. Higher Stromal Expression of Transforming Growth Factor-beta Type II Receptors is Associated with Poorer Prognosis Breast Tumors , 2003, Breast Cancer Research and Treatment.
[25] Richard Dybowski,et al. Clinical applications of artificial neural networks: Theory , 2001 .
[26] M. Guzmán,et al. Delta9-tetrahydrocannabinol inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation. , 2006, Cancer research.
[27] J. Nussbaum,et al. Transcriptional upregulation of interferon-induced protein kinase, PKR, in breast cancer. , 2003, Cancer letters.
[28] Jürgen Wolf,et al. CASPAR: a hierarchical Bayesian approach to predict survival times in cancer from gene expression data , 2006, Bioinform..
[29] Hongyu Zhao,et al. Building pathway clusters from Random Forests classification using class votes , 2008, BMC Bioinformatics.
[30] B. Peter. BOOSTING FOR HIGH-DIMENSIONAL LINEAR MODELS , 2006 .
[31] L. Donehower,et al. Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK–mediated activation of the p16Ink4a-p19Arf pathway , 2004, Nature Genetics.
[32] Masafumi Nakamura,et al. The Hedgehog pathway is a possible therapeutic target for patients with estrogen receptor-negative breast cancer. , 2009, Anticancer research.
[33] F. Stivala,et al. Genotoxic stress leads to centrosome amplification in breast cancer cell lines that have an inactive G1/S cell cycle checkpoint , 2004, Oncogene.
[34] G. Page,et al. Hedgehog signaling and response to cyclopamine differs in epithelial and stromal cells in benign breast and breast cancer , 2006, Cancer biology & therapy.
[35] Mark R. Segal,et al. Regression Trees for Censored Data , 1988 .
[36] Urs Eppenberger,et al. Low E2F1 transcript levels are a strong determinant of favorable breast cancer outcome , 2007, Breast Cancer Research.
[37] K. O’Neill,et al. Can thymidine kinase levels in breast tumors predict disease recurrence? , 1992, Journal of the National Cancer Institute.
[38] Harald Binder,et al. Assessment of survival prediction models based on microarray data , 2007, Bioinform..
[39] Jiri Bartek,et al. Cell-cycle checkpoints and cancer , 2004, Nature.
[40] Brian D. Ripley,et al. Clinical applications of artificial neural networks: Neural networks as statistical methods in survival analysis , 2001 .
[41] Blaise Hanczar,et al. Decorrelation of the True and Estimated Classifier Errors in High-Dimensional Settings , 2007, EURASIP J. Bioinform. Syst. Biol..
[42] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[43] Gun-Hee Kim,et al. Apigenin causes G(2)/M arrest associated with the modulation of p21(Cip1) and Cdc2 and activates p53-dependent apoptosis pathway in human breast cancer SK-BR-3 cells. , 2009, The Journal of nutritional biochemistry.
[44] Anatoly L. Mayburd,et al. Successful anti-cancer drug targets able to pass FDA review demonstrate the identifiable signature distinct from the signatures of random genes and initially proposed targets , 2008, Bioinform..
[45] T. Lumley,et al. Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker , 2000, Biometrics.
[46] E. Appella,et al. The role of the MKK6/p38 MAPK pathway in Wip1-dependent regulation of ErbB2-driven mammary gland tumorigenesis , 2007, Oncogene.
[47] Joseph D. Szustakowski,et al. Extending the pathway analysis framework with a test for transcriptional variance implicates novel pathway modulation during myogenic differentiation , 2007, Bioinform..
[48] Kiyoko F. Aoki-Kinoshita,et al. From genomics to chemical genomics: new developments in KEGG , 2005, Nucleic Acids Res..
[49] Peter Buhlmann,et al. BOOSTING ALGORITHMS: REGULARIZATION, PREDICTION AND MODEL FITTING , 2007, 0804.2752.
[50] Ubiquitinated or sumoylated retinoic acid receptor alpha determines its characteristic and interacting model with retinoid X receptor alpha in gastric and breast cancer cells. , 2004, Journal of molecular endocrinology.
[51] Ian O Ellis,et al. Loss of CD55 Is Associated with Aggressive Breast Tumors , 2004, Clinical Cancer Research.
[52] R Beuscart,et al. Prognostic significance of insulin-like growth factor 1 receptors in human breast cancer. , 1990, Cancer research.
[53] P. Bühlmann. Boosting for high-dimensional linear models , 2006 .
[54] T. Kinsella,et al. BRCA1 activates a G2-M cell cycle checkpoint following 6-thioguanine-induced DNA mismatch damage. , 2007, Cancer research.
[55] A. Jakubowska,et al. CDKN2A-positive breast cancers in young women from Poland , 2007, Breast Cancer Research and Treatment.
[56] Hongzhe Li,et al. A Markov random field model for network-based analysis of genomic data , 2007, Bioinform..
[57] Helmut Strasser,et al. On the Asymptotic Theory of Permutation Statistics , 1999 .
[58] Ludger Evers,et al. Sparse kernel methods for high-dimensional survival data , 2008, Bioinform..
[59] Daohai Zhang,et al. Proteomic Study Reveals That Proteins Involved in Metabolic and Detoxification Pathways Are Highly Expressed in HER-2/neu-positive Breast Cancer* , 2005, Molecular & Cellular Proteomics.
[60] D. Shalloway,et al. Apoptosis of estrogen‐receptor negative breast cancer and colon cancer cell lines by PTPα and src RNAi , 2008, International journal of cancer.
[61] J. Bartlett,et al. Bad expression predicts outcome in patients treated with tamoxifen , 2007, Breast Cancer Research and Treatment.
[62] M. Reiss,et al. Transforming growth factor beta type I receptor kinase mutant associated with metastatic breast cancer. , 1998, Cancer research.
[63] C. Orlandini,et al. Cyclin A and E2F1 overexpression correlate with reduced disease-free survival in node-negative breast cancer patients. , 2006, Anticancer research.
[64] Jiang Gui,et al. Partial Cox regression analysis for high-dimensional microarray gene expression data , 2004, ISMB/ECCB.
[65] Marcel Dettling,et al. BagBoosting for tumor classification with gene expression data , 2004, Bioinform..
[66] Torsten Hothorn,et al. On the Exact Distribution of Maximally Selected Rank Statistics , 2002, Comput. Stat. Data Anal..
[67] Heung-Chin Cheng,et al. Activation of Src in human breast tumor cell lines: elevated levels of phosphotyrosine phosphatase activity that preferentially recognizes the Src carboxy terminal negative regulatory tyrosine 530 , 1999, Oncogene.
[68] Lionel Tarassenko,et al. Non‐linear survival analysis using neural networks , 2004, Statistics in medicine.
[69] Xihong Lin,et al. Sparse linear discriminant analysis for simultaneous testing for the significance of a gene set/pathway and gene selection , 2009, Bioinform..
[70] P. V. van Diest,et al. Expression of growth factors, growth‐inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis , 1998, The Journal of pathology.
[71] Hemant Ishwaran,et al. Random Survival Forests , 2008, Wiley StatsRef: Statistics Reference Online.